Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol for intraoperative tachyarrhythmia during general anesthesia
ChiCTR2400091341Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of landiolol in tachyarrhythmia (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Effective rate of tachycardia control at 11 minutes after initiation of dosing. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
landiolol
03
Conditions
tachyarrhythmia
Beyond the preview
Go deeper on ChiCTR2400091341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091341.